Literature DB >> 25900768

Mitochondrial coupling factor 6 upregulation in hypertension-induced cardiac hypertrophy.

Tao He1, Aili Guan, Yue Shi, Zhiming Ge, Hongyan Dai.   

Abstract

BACKGROUND: Mitochondrial coupling factor 6 (CF6) is a constriction factor in cardiac hypertrophy, whose mechanisms are not fully understood.
MATERIALS AND METHODS: Here, we established cardiac hypertrophy models for feeding spontaneously hypertensive rats (SHRs) aged 10, 20, and 30 weeks. Hemodynamic monitoring was performed during the feeding program to ensure the success of the model.
RESULTS: Cardiac hypertrophy, but not fibrosis, occurred in the 10-, 20-, and 30-week-old SHRs. No significant changes in CF6 gene expression were detected by RT-PCR in any of the SHR groups as compared with the control groups (p > 0.05). ELISA assessment showed that the CF6 protein level in the 20- and 30-week-old SHRs with cardiac hypertrophy was significantly increased (vs. control, p < 0.05).
CONCLUSION: CF6 protein was upregulated in cardiac hypertrophy induced by hypertension; further mechanisms involved in this process should be investigated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25900768     DOI: 10.1007/s00059-015-4301-8

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  24 in total

1.  Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells.

Authors:  Tomohiro Osanai; Masayuki Saitoh; Satoko Sasaki; Hirofumi Tomita; Toshiro Matsunaga; Ken Okumura
Journal:  Hypertension       Date:  2003-10-13       Impact factor: 10.190

2.  Overexpression of coupling factor 6 attenuates exercise-induced physiological cardiac hypertrophy by inhibiting PI3K/Akt signaling in mice.

Authors:  Shigeki Sagara; Tomohiro Osanai; Taihei Itoh; Kei Izumiyama; Shuji Shibutani; Kenji Hanada; Hiroaki Yokoyama; Yuko Yamamoto; Takashi Yokota; Hirofumi Tomita; Koji Magota; Ken Okumura
Journal:  J Hypertens       Date:  2012-04       Impact factor: 4.844

Review 3.  The progression of hypertensive heart disease.

Authors:  Mark H Drazner
Journal:  Circulation       Date:  2011-01-25       Impact factor: 29.690

4.  Cardiac hypertrophy in spontaneously hypertensive rats.

Authors:  S Sen; R C Tarazi; P A Khairallah; F M Bumpus
Journal:  Circ Res       Date:  1974-11       Impact factor: 17.367

5.  Mitochondrial coupling factor 6 is present on the surface of human vascular endothelial cells and is released by shear stress.

Authors:  T Osanai; S Okada; K Sirato; T Nakano; M Saitoh; K Magota; K Okumura
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

6.  Mitochondrial coupling factor 6 as a potent endogenous vasoconstrictor.

Authors:  T Osanai; M Tanaka; T Kamada; T Nakano; K Takahashi; S Okada; K Sirato; K Magota; S Kodama; K Okumura
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

7.  Coupling factor 6 enhances the spontaneous microaggregation of platelets by decreasing cytosolic cAMP irrespective of antiplatelet therapy.

Authors:  Takanori Sukekawa; Tomohiro Osanai; Fumie Nishizaki; Norifumi Metoki; Joji Hagii; Takaatsu Kamada; Minoru Yasujima; Hirofumi Tomita; Koji Magota; Ken Okumura
Journal:  Hypertens Res       Date:  2013-02-07       Impact factor: 3.872

8.  Urinary levels of 2,3-dinor-6-oxo-PGF1 alpha: a reliable index of the production of PGI2 in the spontaneously hypertensive rat.

Authors:  P Falardeau; M Robillard; A Martineau
Journal:  Prostaglandins       Date:  1985-04

9.  Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.

Authors:  J Sadoshima; S Izumo
Journal:  Circ Res       Date:  1993-09       Impact factor: 17.367

Review 10.  Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

Authors:  J N Cohn; R Ferrari; N Sharpe
Journal:  J Am Coll Cardiol       Date:  2000-03-01       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.